Skip to content

AtriCure ATRC Sales returns and allowances

Other financials

Income statement

See full
Revenue$141.2M+14.3%
Gross profit$109.3M+18.0%
Operating income$526.0K+109%
Net income$108.0K+102%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$146.2M+46.3%
Total debt$76.2M-3.1%
Total equity$491.7M+8.2%
Total assets$644.0M+8.8%

Cash flow

See full
Operating cash flow-$4.0M+63.8%
CapEx$3.9M+76.6%
Free cash flow-$7.8M+40.6%

Valuation

See full
Market cap$1.43B-7.9%
Enterprise value$1.36B-11.2%
P/S2.6×-0.6×

Profitability

See full
Gross margin75.6%+0.8pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.7%

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Debt / equity0.2×0.0×
Current ratio4.3×+0.2×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept atrc:SalesReturnsAllowanceTrade.

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's sales returns and allowances.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AtriCure's sales returns and allowances?
AtriCure (ATRC) reported sales returns and allowances of $3.97M in Q1 2026.
How has AtriCure's sales returns and allowances changed year-over-year?
AtriCure's sales returns and allowances increased by 26.4% year-over-year, from $3.14M to $3.97M.
What is the long-term trend for AtriCure's sales returns and allowances?
Over 5 years (2020 to 2025), AtriCure's sales returns and allowances has grown at a 13.0% compound annual growth rate (CAGR), from $1.89M to $3.48M.